BMI1 and breast carcinoma: We evaluated for the first time the oncogene Bmi-1 in plasma in a large series of primary breast carcinomas to investigate the presence at diagnosis of detectable Bmi-1 mRNA in plasma and its possible correlations with clinical-pathological parameters of the tumors and survival of patients.